HomeBDX • NYSE
add
Becton Dickinson and Co
Previous close
$234.68
Day range
$235.56 - $238.00
Year range
$229.40 - $287.32
Market cap
68.35B USD
Avg Volume
1.28M
P/E ratio
52.09
Dividend yield
1.61%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 5.04B | 4.65% |
Operating expense | 1.47B | -5.47% |
Net income | 537.00M | 16.74% |
Net profit margin | 10.64 | 11.53% |
Earnings per share | 3.17 | 10.84% |
EBITDA | 1.41B | 13.02% |
Effective tax rate | 15.17% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.18B | 59.79% |
Total assets | 54.16B | -0.44% |
Total liabilities | 28.51B | -0.68% |
Total equity | 25.65B | — |
Shares outstanding | 289.52M | — |
Price to book | 2.65 | — |
Return on assets | 3.92% | — |
Return on capital | 4.91% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 537.00M | 16.74% |
Cash from operations | 514.00M | 177.84% |
Cash from investing | -1.06B | -353.22% |
Cash from financing | 1.70B | 24.54% |
Net change in cash | 1.16B | -12.39% |
Free cash flow | 476.75M | 36.26% |
About
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
BD is ranked #177 in the 2021 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2020.
In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock.
In April 2017, C. R. Bard announced that it would be acquired by Becton, Dickinson and Company. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard. Wikipedia
CEO
Founded
1897
Headquarters
Website
Employees
70,000
